Descriptor English: | Tartrate-Resistant Acid Phosphatase | ||||||
Descriptor Spanish: |
Fosfatasa Ácida Tartratorresistente
| ||||||
Descriptor Portuguese: | Fosfatase Ácida Resistente a Tartarato | ||||||
Descriptor French: | Tartrate-resistant acid phosphatase | ||||||
Entry term(s): |
AcPase V Acid Phosphatase V Acid Phosphatase, Tartrate-Resistant Phosphatase V, Acid Phosphatase, Tartrate-Resistant Acid TRAP Type 5 AcPase TRAcP Tartrate Resistant Acid Phosphatase Tartrate Resistant Acid Phosphatase Type 5 Tartrate-Resistant Acid Phosphatase Type 5 Type 5 Acid Phosphatase Uteroferrin V, AcPase V, Acid Phosphatase |
||||||
Tree number(s): |
D08.811.277.352.650.025.500 D08.811.277.352.650.625.862 D12.776.476.559.862 |
||||||
RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D000071681 | ||||||
Scope note: | One of several acid phosphatases in humans, other mammals, plants, and a few prokaryotes. The protein fold of tartrate-resistant acid phosphatase (TRAP) resembles that of the catalytic domain of plant purple acid phosphatase and other serine/threonine-protein phosphatases that also contain a metallophosphoesterase domain. One gene produces the various forms which include purple acid phosphatases from spleen and other tissues. Tartrate-resistant acid phosphatase is a biomarker for pathological states in which it is over-expressed. Such conditions include GAUCHER DISEASE; HODGKIN DISEASE; BONE RESORPTION; and NEOPLASM METASTASIS. |
||||||
Allowable Qualifiers: |
AD administration & dosage AE adverse effects AI antagonists & inhibitors AN analysis BI biosynthesis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis DE drug effects DF deficiency EC economics GE genetics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PH physiology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UL ultrastructure UR urine |
||||||
Registry Number: | EC 3.1.3.2 | ||||||
Public MeSH Note: | 2017; TARTRATE-RESISTANT ACID PHOSPHATASE was indexed under ACID PHOSPHATASE and ISOENZYMES 1995-2016 |
||||||
History Note: | 2017 (1995) |
||||||
DeCS ID: | 56474 | ||||||
Unique ID: | D000071681 | ||||||
Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||||
Date Established: | 2017/01/01 | ||||||
Date of Entry: | 2016/07/08 | ||||||
Revision Date: | 2016/06/30 |
-
-
CHEMICALS AND DRUGS
Enzymes and Coenzymes [D08]Enzymes and Coenzymes -
CHEMICALS AND DRUGS
Enzymes and Coenzymes [D08]Enzymes and Coenzymes -
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins
|
Tartrate-Resistant Acid Phosphatase
- Preferred
TRAP Type 5 AcPase
- Narrower
Uteroferrin
- Narrower
Concept UI |
M0246521 |
Scope note | One of several acid phosphatases in humans, other mammals, plants, and a few prokaryotes. The protein fold of tartrate-resistant acid phosphatase (TRAP) resembles that of the catalytic domain of plant purple acid phosphatase and other serine/threonine-protein phosphatases that also contain a metallophosphoesterase domain. One gene produces the various forms which include purple acid phosphatases from spleen and other tissues. Tartrate-resistant acid phosphatase is a biomarker for pathological states in which it is over-expressed. Such conditions include GAUCHER DISEASE; HODGKIN DISEASE; BONE RESORPTION; and NEOPLASM METASTASIS. |
Preferred term | Tartrate-Resistant Acid Phosphatase |
Entry term(s) |
Acid Phosphatase, Tartrate-Resistant Phosphatase, Tartrate-Resistant Acid TRAcP Tartrate Resistant Acid Phosphatase |
Concept UI |
M000618272 |
Preferred term | TRAP Type 5 AcPase |
Entry term(s) |
AcPase V Acid Phosphatase V Phosphatase V, Acid Tartrate Resistant Acid Phosphatase Type 5 Tartrate-Resistant Acid Phosphatase Type 5 Type 5 Acid Phosphatase V, AcPase V, Acid Phosphatase |
Concept UI |
M000617677 |
Preferred term | Uteroferrin |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey